Alphastox writeuphttps://us5.campaign-archive1.com/?u=95719943a1821b57689e12e4d&id=d1e2e624b8&e=d3d829438c Dear Alphastox Subscribers, Now that the medical marijuana market is gaining popularity, it is important to re-evaluate who the major players are and who is worth investing in. Health Canada expects the marijuana market will create a private industry eventually worth some $1.3 billion in sales annually with perhaps half a million customers. The market will continue to grow and be successful as more governments make it legal and as more companies gain licenses. Although Chlormet Technologies (PUF.C) has been laying low for the past few months, they have recently began to pick up pace again and move forward with their deals and developments in both Canada and the United States. I introduced you to Chlormet Technologies (PUF.C) back in April at $0.20 and the stock soon jumped to a high of $0.67 two days later. The stock has since come down to a new base of around $0.16-$0.17 but I think with what they have coming down the pipe, we could be in for a real treat. The company has continued to make huge progress with Health Canada and even recently announced that their AAA Heidelberg facility in London Ontario has been given notification by Health Canada that its application is in the enhanced screening stage which is a massive feat for the company. Many never even get to that stage of development so it only validates the company’s work which will all hopefully soon payoff with an eventual license. As the company awaits for this to happen, they have set their sights on an even bigger opportunity…Washington State. Chlormet has entered into an LOI agreement with Babcock Bench Farms (BBF) a company which plans to produce marijuana for the rapidly expanding Washington State recreational marijuana market. BBF has a Tier 3 marijuana license in Washington State, and intends to produce and process in a 21,000 sq. ft. facility. Their skilled and experienced team will be a great asset for Chlormet and with Washington State predicting annual sales of ~$1 billion dollars the opportunity seems like a real no brainer. Health Canada has been slow at approving licenses so it is smart of Chlormet, and potential investors, to look across the border and penetrate an even bigger market. Currently, Canada has approximately 40,000 registered medical marijuana patients….Washington state has over 400,000 recreational users….. PUF.C also just announced this morning that they have raised a total of $752,000 through the exercise of just over 10,000,000 warrants. The funds raised will be primarily used towards the building of the planned Washington State facility, and, if needed, additional funds for AAA Heidelberg. This is a massive feat for the company and should give investors a sense of stability and confidence that their current shareholders are willing to write checks into the deal and help the company grow. Having supportive shareholders is a very important asset to have. I love to support deals with quality, long-term shareholders that believe in the story. PUF shareholders understand the true potential of the play and realize that if they are able to generate the revenue they hope to in Washington State, PUF’s valuation would drastically change overnight. I personally wrote an additional $30,000 check into the company and continue to support it everyday. The next three months is going to be absolutely crucial for PUF.C as they hope to tap into the Washington State market and position themselves to generate big revenue in 2015. Now is the time to keep PUF.C on your radar screens! As always, if you have any questions, please do not hesitate to get in touch with me anytime. I look forward to hearing from you. Best, Etienne Disclosure: Etienne Moshevich is a shareholder of Chlormet Technologies